Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced that the release date
of the Annual Report 2009 has been changed. The report will now be published on
15 February 2010. The report was previously planned for release on 5 March
2010.

Thus the financial calendar looks as follows:

Announcement of full-year results 2009: 15 February 2010

The annual general meeting is scheduled to be held on: 14 April 2010

Interim report for the period 1 January 2010 to 31 March 2010: 19 May 2010

Interim report for the period 1 January 2010 to 30 June 2010: 19 August 2010

Interim report for the period 1 Jan 2010 to 30 Sept 2010: 12 November 2010

Additional information:
Lars Kongsbak, CEO, phone +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2164)

About Exiqon:
Exiqon's products are based on the proprietary LNA? technology. This
technology offers unique advantages for detection of miRNA biomarkers for life
science researchers, drug developers and cancer treating physicians working
towards personalizing medicine. Exiqon operates in two business areas: Exiqon
Life Sciences has established a position for itself as one of the market's
leading providers of miRNA research products for miRNA analysis in cells.
Research products are used by academia, biotech and pharmaceutical companies
around the world to make groundbreaking discoveries about the correlation
between gene activity and the development of cancer and other diseases. Exiqon
Life Sciences is also collaborating with pharmaceutical companies in their
effort to develop new medicines based on miRNA as biological markers (Exiqon
Pharma Services). Exiqon Diagnostics is developing a series of new molecular
diagnostic products based on miRNA. Exiqon's goal is to gain a market-leading
position for miRNA-based diagnostics. Exiqon is listed on the NASDAQ OMX in
Copenhagen. For more information about us, please visit www.exiqon.com.

Forward-looking statement:
Certain parts of this release contain forward-looking information with respect
to the plans, projections and future performance of the company, each of which
involves significant uncertainties. The company's actual results may differ
materially from the information set forth in these statements. This is an
English translation of the interim report prepared in Danish. In case of any
discrepancies between the Danish version and this English translation thereof,
the Danish version shall prevail.

See full annoncement in the attached pdf-file.

announcement_1_2010_change_to_financial_calendar.pdf